Skip to Content

Akzo Nobel NV

AKZA: XAMS (NLD)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€87.00YrdxgxMbgdrgm

AkzoNobel Delivers Sharp Growth in Q2 but Earnings Miss Expectations; Shares Fairly Valued

Narrow-moat AkzoNobel reported second-quarter EBIT of EUR 335 million, up 41% over 2020 but missing the Visible Alpha consensus. Profits were negatively impacted by sharply rising raw material inflation, leading to margins below consensus. For the full year, we were already below consensus and don’t expect to make any material changes to our forecast or EUR 99 fair value estimate based on second-quarter results. At current levels, the shares look fairly valued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of AKZA so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center